HIV

Decline in cancer incidence rates most likely driven by modern antiretroviral therapies.

The final part of a 4-part interview with an infectious disease expert examines the furture treatment landscape and caring for an aging HIV population.

Beginning April 25, Walgreens Healthcare Clinic locations in select markets will offer testing services for sexually transmitted infections such as HIV, Hepatitis B and C, chlamydia, and gonorrhea.

Kevin James, RPh, MBA, vice president of Payer Strategy at US Bioservices, discusses optimal support for distribution of specialty therapies.

The third of a 4-part interview with an infectious disease expert discusses the impact of specialty drugs and the potential loss of funding to HIV treatment programs.

Challenges to specialty pharmacy profits will need to be overcome for smaller pharmacies to survive.

Regulating emotion may help reduce the risk of HIV spreading among high-risk populations.

A recently-published study evaluated the relationship between injection drug use and immune activation in people who inject drugs (PWID) and who have or do not have HIV.

Novel therapeutic approach may help cure patients with HIV in the future.

Mark Wainberg, PhD was an influential researcher from the start of the AIDS epidemic.

Part 1 of a 4-part interview with an infectious disease expert explores treatment advances in HIV since the AIDS epidemic in the 1980s.

Nearly 70% of patients with HIV take dietary supplements with their antiretroviral therapy.

Many patients who have HIV use complementary and alternative medicine (CAM) to help handle their health issues.

Determining the composition of HIV’s glycoprotein can help fight the virus.

Novel drug delivery system steadily releases preventive HIV drugs over an extended period of time.

Technique will help scientists develop an effective HIV vaccine.

Sheila Arquette, RPh, director of Pharmacy Services at Independent Health, discusses the impact of prior authorizations on specialty pharmacy.

The dream of an HIV cure will only be realized if all 35 million people who are living with the virus adhere to treatment.

Poorer health outcomes found in perinatally HIV-infected youth.

Countries where high risk populations face punitive laws do not have access to critical HIV prevention services.

Although statistics gathered in 2016 indicate that we've made significant progress in reaching patients with HIV, only approximately 60% of them are in active treatment.

Cytomegalovirus disease coinfection without symptoms is common in people with HIV.

Chronic oral dosing of HIV treatments can have significant complications caused by high pill burden.

Research seeks to improve the impact of household-based HIV testing and the link to care by community HIV care providers.

The smartphone hit the shelves recently.